HEADER BIOSYNTHETIC PROTEIN 06-JAN-09 3FPZ TITLE SACCHAROMYCES CEREVISIAE THI4P IS A SUICIDE THIAMIN THIAZOLE SYNTHASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: THIAZOLE BIOSYNTHETIC ENZYME; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: YEAST THIAZOLE SYNTHASE; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE; SOURCE 3 ORGANISM_COMMON: YEAST; SOURCE 4 ORGANISM_TAXID: 4932; SOURCE 5 GENE: THI4, ESP35, MOL1, YGR144W, G6620; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: B834(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS THIAZOLE BIOSYNTHETIC ENZYME IN YEAST, FAD, MITOCHONDRION, NAD, KEYWDS 2 THIAMINE BIOSYNTHESIS, TRANSIT PEPTIDE, BIOSYNTHETIC PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.BALE,A.CHATTERJEE,P.C.DORRESTEIN,T.P.BEGLEY,S.E.EALICK REVDAT 5 06-SEP-23 3FPZ 1 REMARK LINK REVDAT 4 01-NOV-17 3FPZ 1 REMARK REVDAT 3 09-NOV-11 3FPZ 1 JRNL TITLE REMARK REVDAT 2 13-JUL-11 3FPZ 1 JRNL AUTHOR REVDAT 1 19-JAN-10 3FPZ 0 SPRSDE 19-JAN-10 3FPZ 2GJC JRNL AUTH A.CHATTERJEE,N.D.ABEYDEERA,S.BALE,P.J.PAI,P.C.DORRESTEIN, JRNL AUTH 2 D.H.RUSSELL,S.E.EALICK,T.P.BEGLEY JRNL TITL SACCHAROMYCES CEREVISIAE THI4P IS A SUICIDE THIAMINE JRNL TITL 2 THIAZOLE SYNTHASE. JRNL REF NATURE V. 478 542 2011 JRNL REFN ISSN 0028-0836 JRNL PMID 22031445 JRNL DOI 10.1038/NATURE10503 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.T.JURGENSON,A.CHATTERJEE,T.P.BEGLEY,S.E.EALICK REMARK 1 TITL STRUCTURAL INSIGHTS INTO THE FUNCTION OF THE THIAMIN REMARK 1 TITL 2 BIOSYNTHETIC ENZYME THI4 FROM SACCHAROMYCES CEREVISIAE. REMARK 1 REF BIOCHEMISTRY V. 45 11061 2006 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 16964967 REMARK 1 DOI 10.1021/BI061025Z REMARK 2 REMARK 2 RESOLUTION. 1.82 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0066 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.82 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.75 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 63274 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3212 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.82 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4248 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.34 REMARK 3 BIN R VALUE (WORKING SET) : 0.2490 REMARK 3 BIN FREE R VALUE SET COUNT : 228 REMARK 3 BIN FREE R VALUE : 0.2960 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4627 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 91 REMARK 3 SOLVENT ATOMS : 491 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.26 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.133 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.129 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.085 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.694 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4848 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6599 ; 1.443 ; 1.977 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 619 ; 6.581 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 190 ;35.456 ;24.526 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 768 ;13.783 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;15.167 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 751 ; 0.105 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3636 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3076 ; 0.785 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4929 ; 1.428 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1772 ; 1.747 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1668 ; 2.779 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 16 A 326 6 REMARK 3 1 B 16 B 326 6 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 LOOSE POSITIONAL 1 A (A): 2306 ; 0.390 ; 5.000 REMARK 3 LOOSE THERMAL 1 B (A**2): 2306 ; 0.830 ;10.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3FPZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JAN-09. REMARK 100 THE DEPOSITION ID IS D_1000050897. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-AUG-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : A1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98310 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 63274 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.820 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : 0.04500 REMARK 200 R SYM (I) : 0.04500 REMARK 200 FOR THE DATA SET : 22.6690 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.82 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.89 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.25600 REMARK 200 R SYM FOR SHELL (I) : 0.25600 REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1RP0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.65-2.00 M LI2SO4, 100 MM HEPES, PH REMARK 280 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 4 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z REMARK 290 4555 Y,-X,Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 8555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 70.34800 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 70.34800 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 36.66250 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 70.34800 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 70.34800 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 36.66250 REMARK 290 SMTRY1 7 0.000000 -1.000000 0.000000 70.34800 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 70.34800 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 36.66250 REMARK 290 SMTRY1 8 0.000000 1.000000 0.000000 70.34800 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 70.34800 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 36.66250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: OCTAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 60810 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 74210 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -367.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 140.69600 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 140.69600 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 -1.000000 0.000000 140.69600 REMARK 350 BIOMT2 3 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 -1.000000 0.000000 0.000000 140.69600 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ALA A 3 REMARK 465 THR A 4 REMARK 465 SER A 5 REMARK 465 THR A 6 REMARK 465 ALA A 7 REMARK 465 THR A 8 REMARK 465 SER A 9 REMARK 465 THR A 10 REMARK 465 SER A 11 REMARK 465 ALA A 12 REMARK 465 SER A 13 REMARK 465 GLN A 14 REMARK 465 LEU A 15 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 ALA B 3 REMARK 465 THR B 4 REMARK 465 SER B 5 REMARK 465 THR B 6 REMARK 465 ALA B 7 REMARK 465 THR B 8 REMARK 465 SER B 9 REMARK 465 THR B 10 REMARK 465 SER B 11 REMARK 465 ALA B 12 REMARK 465 SER B 13 REMARK 465 GLN B 14 REMARK 465 LEU B 15 REMARK 465 GLU B 180 REMARK 465 LYS B 181 REMARK 465 GLY B 182 REMARK 465 GLU B 183 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 16 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A 180 CG CD OE1 OE2 REMARK 470 LYS A 181 CG CD CE NZ REMARK 470 HIS A 200 CG ND1 CD2 CE1 NE2 REMARK 470 THR A 202 OG1 CG2 REMARK 470 ASP A 238 CG OD1 OD2 REMARK 470 LYS A 257 CG CD CE NZ REMARK 470 HIS B 16 CG ND1 CD2 CE1 NE2 REMARK 470 VAL B 184 CG1 CG2 REMARK 470 HIS B 200 CG ND1 CD2 CE1 NE2 REMARK 470 THR B 202 OG1 CG2 REMARK 470 LEU B 224 CG CD1 CD2 REMARK 470 GLN B 254 CG CD OE1 NE2 REMARK 470 GLN B 256 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 73 54.45 -96.08 REMARK 500 THR A 179 113.79 74.58 REMARK 500 GLU A 180 34.73 -168.40 REMARK 500 GLN A 203 122.27 -35.03 REMARK 500 PHE A 241 -152.88 -112.21 REMARK 500 ALA B 73 55.66 -95.70 REMARK 500 PRO B 178 158.16 -48.54 REMARK 500 HIS B 200 -119.67 143.49 REMARK 500 GLN B 203 128.21 -39.55 REMARK 500 PRO B 240 -72.33 -82.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 DHA A 205 MET A 206 144.84 REMARK 500 DHA B 205 MET B 206 148.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AHZ A 1100 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 327 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 328 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AHZ B 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 327 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1RP0 RELATED DB: PDB REMARK 900 RELATED ID: 2GJC RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 AUTHORS STATE THAT THE FORMATION OF DHA FROM CYS IS DUE TO THE REMARK 999 REACTION CATALYZED BY THE ENZYME. DBREF 3FPZ A 1 326 UNP P32318 THI4_YEAST 1 326 DBREF 3FPZ B 1 326 UNP P32318 THI4_YEAST 1 326 SEQADV 3FPZ DHA A 205 UNP P32318 CYS 205 SEE REMARK 999 SEQADV 3FPZ DHA B 205 UNP P32318 CYS 205 SEE REMARK 999 SEQRES 1 A 326 MET SER ALA THR SER THR ALA THR SER THR SER ALA SER SEQRES 2 A 326 GLN LEU HIS LEU ASN SER THR PRO VAL THR HIS CYS LEU SEQRES 3 A 326 SER ASP ILE VAL LYS LYS GLU ASP TRP SER ASP PHE LYS SEQRES 4 A 326 PHE ALA PRO ILE ARG GLU SER THR VAL SER ARG ALA MET SEQRES 5 A 326 THR SER ARG TYR PHE LYS ASP LEU ASP LYS PHE ALA VAL SEQRES 6 A 326 SER ASP VAL ILE ILE VAL GLY ALA GLY SER SER GLY LEU SEQRES 7 A 326 SER ALA ALA TYR VAL ILE ALA LYS ASN ARG PRO ASP LEU SEQRES 8 A 326 LYS VAL CYS ILE ILE GLU SER SER VAL ALA PRO GLY GLY SEQRES 9 A 326 GLY SER TRP LEU GLY GLY GLN LEU PHE SER ALA MET VAL SEQRES 10 A 326 MET ARG LYS PRO ALA HIS LEU PHE LEU GLN GLU LEU GLU SEQRES 11 A 326 ILE PRO TYR GLU ASP GLU GLY ASP TYR VAL VAL VAL LYS SEQRES 12 A 326 HIS ALA ALA LEU PHE ILE SER THR VAL LEU SER LYS VAL SEQRES 13 A 326 LEU GLN LEU PRO ASN VAL LYS LEU PHE ASN ALA THR CYS SEQRES 14 A 326 VAL GLU ASP LEU VAL THR ARG PRO PRO THR GLU LYS GLY SEQRES 15 A 326 GLU VAL THR VAL ALA GLY VAL VAL THR ASN TRP THR LEU SEQRES 16 A 326 VAL THR GLN ALA HIS GLY THR GLN CYS DHA MET ASP PRO SEQRES 17 A 326 ASN VAL ILE GLU LEU ALA GLY TYR LYS ASN ASP GLY THR SEQRES 18 A 326 ARG ASP LEU SER GLN LYS HIS GLY VAL ILE LEU SER THR SEQRES 19 A 326 THR GLY HIS ASP GLY PRO PHE GLY ALA PHE CYS ALA LYS SEQRES 20 A 326 ARG ILE VAL ASP ILE ASP GLN ASN GLN LYS LEU GLY GLY SEQRES 21 A 326 MET LYS GLY LEU ASP MET ASN HIS ALA GLU HIS ASP VAL SEQRES 22 A 326 VAL ILE HIS SER GLY ALA TYR ALA GLY VAL ASP ASN MET SEQRES 23 A 326 TYR PHE ALA GLY MET GLU VAL ALA GLU LEU ASP GLY LEU SEQRES 24 A 326 ASN ARG MET GLY PRO THR PHE GLY ALA MET ALA LEU SER SEQRES 25 A 326 GLY VAL HIS ALA ALA GLU GLN ILE LEU LYS HIS PHE ALA SEQRES 26 A 326 ALA SEQRES 1 B 326 MET SER ALA THR SER THR ALA THR SER THR SER ALA SER SEQRES 2 B 326 GLN LEU HIS LEU ASN SER THR PRO VAL THR HIS CYS LEU SEQRES 3 B 326 SER ASP ILE VAL LYS LYS GLU ASP TRP SER ASP PHE LYS SEQRES 4 B 326 PHE ALA PRO ILE ARG GLU SER THR VAL SER ARG ALA MET SEQRES 5 B 326 THR SER ARG TYR PHE LYS ASP LEU ASP LYS PHE ALA VAL SEQRES 6 B 326 SER ASP VAL ILE ILE VAL GLY ALA GLY SER SER GLY LEU SEQRES 7 B 326 SER ALA ALA TYR VAL ILE ALA LYS ASN ARG PRO ASP LEU SEQRES 8 B 326 LYS VAL CYS ILE ILE GLU SER SER VAL ALA PRO GLY GLY SEQRES 9 B 326 GLY SER TRP LEU GLY GLY GLN LEU PHE SER ALA MET VAL SEQRES 10 B 326 MET ARG LYS PRO ALA HIS LEU PHE LEU GLN GLU LEU GLU SEQRES 11 B 326 ILE PRO TYR GLU ASP GLU GLY ASP TYR VAL VAL VAL LYS SEQRES 12 B 326 HIS ALA ALA LEU PHE ILE SER THR VAL LEU SER LYS VAL SEQRES 13 B 326 LEU GLN LEU PRO ASN VAL LYS LEU PHE ASN ALA THR CYS SEQRES 14 B 326 VAL GLU ASP LEU VAL THR ARG PRO PRO THR GLU LYS GLY SEQRES 15 B 326 GLU VAL THR VAL ALA GLY VAL VAL THR ASN TRP THR LEU SEQRES 16 B 326 VAL THR GLN ALA HIS GLY THR GLN CYS DHA MET ASP PRO SEQRES 17 B 326 ASN VAL ILE GLU LEU ALA GLY TYR LYS ASN ASP GLY THR SEQRES 18 B 326 ARG ASP LEU SER GLN LYS HIS GLY VAL ILE LEU SER THR SEQRES 19 B 326 THR GLY HIS ASP GLY PRO PHE GLY ALA PHE CYS ALA LYS SEQRES 20 B 326 ARG ILE VAL ASP ILE ASP GLN ASN GLN LYS LEU GLY GLY SEQRES 21 B 326 MET LYS GLY LEU ASP MET ASN HIS ALA GLU HIS ASP VAL SEQRES 22 B 326 VAL ILE HIS SER GLY ALA TYR ALA GLY VAL ASP ASN MET SEQRES 23 B 326 TYR PHE ALA GLY MET GLU VAL ALA GLU LEU ASP GLY LEU SEQRES 24 B 326 ASN ARG MET GLY PRO THR PHE GLY ALA MET ALA LEU SER SEQRES 25 B 326 GLY VAL HIS ALA ALA GLU GLN ILE LEU LYS HIS PHE ALA SEQRES 26 B 326 ALA MODRES 3FPZ DHA A 205 SER 2-AMINO-ACRYLIC ACID MODRES 3FPZ DHA B 205 SER 2-AMINO-ACRYLIC ACID HET DHA A 205 5 HET DHA B 205 5 HET AHZ A1100 38 HET SO4 A 327 5 HET SO4 A 328 5 HET AHZ B1101 38 HET SO4 B 327 5 HETNAM DHA 2-AMINO-ACRYLIC ACID HETNAM AHZ ADENOSINE DIPHOSPHATE 5-(BETA-ETHYL)-4-METHYL-THIAZOLE- HETNAM 2 AHZ 2-CARBOXYLIC ACID HETNAM SO4 SULFATE ION HETSYN DHA 2,3-DIDEHYDROALANINE FORMUL 1 DHA 2(C3 H5 N O2) FORMUL 3 AHZ 2(C17 H19 N6 O12 P2 S 3-) FORMUL 4 SO4 3(O4 S 2-) FORMUL 8 HOH *491(H2 O) HELIX 1 1 HIS A 16 THR A 20 5 5 HELIX 2 2 ARG A 44 PHE A 63 1 20 HELIX 3 3 GLY A 74 ARG A 88 1 15 HELIX 4 4 ALA A 122 LEU A 129 1 8 HELIX 5 5 HIS A 144 GLN A 158 1 15 HELIX 6 6 THR A 194 GLN A 198 1 5 HELIX 7 7 ALA A 243 ASP A 253 1 11 HELIX 8 8 ASP A 265 SER A 277 1 13 HELIX 9 9 GLY A 290 GLY A 298 1 9 HELIX 10 10 PHE A 306 ALA A 326 1 21 HELIX 11 11 ARG B 44 PHE B 63 1 20 HELIX 12 12 GLY B 74 ARG B 88 1 15 HELIX 13 13 GLY B 109 PHE B 113 5 5 HELIX 14 14 ALA B 122 LEU B 129 1 8 HELIX 15 15 HIS B 144 GLN B 158 1 15 HELIX 16 16 THR B 194 GLN B 198 1 5 HELIX 17 17 ALA B 243 ASP B 253 1 11 HELIX 18 18 ASP B 265 SER B 277 1 13 HELIX 19 19 GLY B 290 GLY B 298 1 9 HELIX 20 20 PHE B 306 ALA B 326 1 21 SHEET 1 A 4 VAL A 65 SER A 66 0 SHEET 2 A 4 ASN A 209 LEU A 213 1 O GLU A 212 N SER A 66 SHEET 3 A 4 THR A 185 TRP A 193 -1 N THR A 191 O ASN A 209 SHEET 4 A 4 THR A 168 ARG A 176 -1 N CYS A 169 O ASN A 192 SHEET 1 B 6 VAL A 162 PHE A 165 0 SHEET 2 B 6 VAL A 93 ILE A 96 1 N ILE A 95 O LYS A 163 SHEET 3 B 6 VAL A 68 VAL A 71 1 N VAL A 68 O CYS A 94 SHEET 4 B 6 VAL A 230 SER A 233 1 O LEU A 232 N ILE A 69 SHEET 5 B 6 MET A 286 PHE A 288 1 O TYR A 287 N SER A 233 SHEET 6 B 6 GLY A 278 ALA A 279 -1 N GLY A 278 O PHE A 288 SHEET 1 C 3 MET A 116 ARG A 119 0 SHEET 2 C 3 TYR A 139 VAL A 142 -1 O VAL A 142 N MET A 116 SHEET 3 C 3 GLU A 134 ASP A 135 -1 N GLU A 134 O VAL A 141 SHEET 1 D 4 VAL B 65 SER B 66 0 SHEET 2 D 4 ASN B 209 LEU B 213 1 O GLU B 212 N SER B 66 SHEET 3 D 4 VAL B 186 TRP B 193 -1 N THR B 191 O ASN B 209 SHEET 4 D 4 THR B 168 THR B 175 -1 N GLU B 171 O VAL B 190 SHEET 1 E 6 VAL B 162 PHE B 165 0 SHEET 2 E 6 VAL B 93 ILE B 96 1 N ILE B 95 O LYS B 163 SHEET 3 E 6 VAL B 68 VAL B 71 1 N VAL B 68 O CYS B 94 SHEET 4 E 6 VAL B 230 SER B 233 1 O LEU B 232 N ILE B 69 SHEET 5 E 6 MET B 286 PHE B 288 1 O TYR B 287 N SER B 233 SHEET 6 E 6 GLY B 278 ALA B 279 -1 N GLY B 278 O PHE B 288 SHEET 1 F 3 MET B 116 ARG B 119 0 SHEET 2 F 3 TYR B 139 VAL B 142 -1 O VAL B 142 N MET B 116 SHEET 3 F 3 GLU B 134 ASP B 135 -1 N GLU B 134 O VAL B 141 LINK C CYS A 204 N DHA A 205 1555 1555 1.35 LINK C DHA A 205 N MET A 206 1555 1555 1.35 LINK C CYS B 204 N DHA B 205 1555 1555 1.35 LINK C DHA B 205 N MET B 206 1555 1555 1.34 CISPEP 1 LYS A 120 PRO A 121 0 13.42 CISPEP 2 GLU A 180 LYS A 181 0 3.50 CISPEP 3 HIS A 200 GLY A 201 0 -3.01 CISPEP 4 CYS A 204 DHA A 205 0 6.96 CISPEP 5 LYS B 120 PRO B 121 0 12.96 CISPEP 6 VAL B 184 THR B 185 0 -2.27 CISPEP 7 ALA B 199 HIS B 200 0 -0.73 CISPEP 8 CYS B 204 DHA B 205 0 22.53 SITE 1 AC1 31 GLY A 72 GLY A 74 SER A 75 SER A 76 SITE 2 AC1 31 ILE A 96 GLU A 97 SER A 98 SER A 99 SITE 3 AC1 31 GLY A 104 GLY A 105 VAL A 170 ASP A 207 SITE 4 AC1 31 THR A 234 THR A 235 GLY A 236 HIS A 237 SITE 5 AC1 31 PHE A 241 GLY A 242 GLY A 290 MET A 291 SITE 6 AC1 31 ARG A 301 MET A 302 GLY A 303 THR A 305 SITE 7 AC1 31 MET A 309 HOH A 331 HOH A 360 HOH A 364 SITE 8 AC1 31 HOH A 385 HOH A 423 HOH A 846 SITE 1 AC2 3 LYS A 32 GLU A 33 GLU B 33 SITE 1 AC3 3 TYR A 82 LYS A 155 HOH A 422 SITE 1 AC4 32 GLY B 72 GLY B 74 SER B 75 SER B 76 SITE 2 AC4 32 ILE B 96 GLU B 97 SER B 98 SER B 99 SITE 3 AC4 32 GLY B 104 GLY B 105 CYS B 169 VAL B 170 SITE 4 AC4 32 ASP B 207 THR B 234 THR B 235 GLY B 236 SITE 5 AC4 32 HIS B 237 PHE B 241 GLY B 290 MET B 291 SITE 6 AC4 32 ARG B 301 MET B 302 GLY B 303 THR B 305 SITE 7 AC4 32 MET B 309 HOH B 334 HOH B 355 HOH B 365 SITE 8 AC4 32 HOH B 411 HOH B 418 HOH B 420 HOH B1085 SITE 1 AC5 3 TYR B 82 LYS B 155 HOH B 404 CRYST1 140.696 140.696 73.325 90.00 90.00 90.00 I 4 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007108 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007108 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013638 0.00000